Parathyroid hormone-related protein (PTHrP) is the cause of humoral hypercalcaemia of malignancy and interacts with parathyroid hormone (PTH) receptors. Breast cancer cells produce PTHrP in vitro and in vivo. The breast cancer cell line MCF-7, which products PTHrP and expresses PTHrP receptors, prol
Hormone receptors in breast cancer: A conservative determination of receptors' presence in tissue and ipsilateral normal mammary gland
β Scribed by F. Badellino; G. Canavese; A. Catturich; G. Battistini; G. Amoretti; S. Bertoglio; F. Boccardo; M. Paganuzzi; G. Tanara
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 365 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Estrogen (ER) and progesterone (PgR) receptors were evaluated in the tumor tissue (T) and in the mammary gland far from malignancy (D) in 36 breast cancers. Results were correlated with the pathological grading of the tumor and the axillary nodal status. It is suggested that a lower cancer malignancy with negative nodes and lower values of pathological grading (Gl-G2) may be associated with a high level of ER in the mammary parenchyma far from the tumor (D).
π SIMILAR VOLUMES
## Abstract We have undertaken a study to examine whether the difference in breast cancer incidence between 2 populations of similar genetic background is reflected in a similar pattern of estrogen receptor Ξ± expression in normal mammary gland. Study participants were 92 Japanese women from Sapporo
## Abstract A functional promoter polymorphism in the progesterone receptor (__PR__) gene previously has been associated with an increased risk of postmenopausal breast cancer. Whether the relationship between genetic variation in __PR__ and risk of breast cancer is modified by postmenopausal hormo
## Abstract The epidermal growth factor receptor (EGFR) exhibits an inverse correlation with estrogen receptor (ER) expression in the majority of breast cancers, predicting a poor response to endocrine therapy and poor survival rate. Inappropriate overexpression of EGFR in breast cancer is associat